ObsEva R&D Day Showcases Multiple Women’s Health Programs and Outlines Plans for Transition to Commercial Operations

Ads

You May Also Like

ContraFect Appoints Lisa Ricciardi as Chief Operating Officer

YONKERS, N.Y., Oct. 05, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a biotechnology company ...

Biocartis Group NV: BIOCARTIS ANNOUNCES H1 2018 RESULTS

PRESS RELEASE: REGULATED INFORMATION Thursday, 6 September 2018, 07:00 CEST BIOCARTIS ANNOUNCES H1 2018 RESULTS ...